CoVIg-19 Plasma Alliance veröffentlicht Topline-Ergebnisse der von den NIH mitfinanzierten klinischen Studie mit dem COVID-19-Hyperimmunglobulin-Prüfmedikament finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. At the end of a three-month period, the capacity will be returned to Takeda to resume critical manufacturing for the planned launch of its dengue vaccine, subject to regulatory approvals.
“We are pleased to work with IDT to support Janssen’s efforts to make its COVID-19 vaccine available and accessible to as much of the world as possible,” said Rajeev Venkayya, President, Global Vaccine Business Unit at Takeda. “We also recognize the massive unmet need for a dengue vaccine and will work
Takeda and IDT Support Manufacturing of Johnson & Johnson’s COVID-19 Vaccine
Monday, March 15, 2021 5:35PM IST (12:05PM GMT)
− Takeda will make manufacturing capacity available at IDT’s facilities in Germany
Takeda Pharmaceutical Company Limited
(TSE:4502/NYSE:TAK) (“Takeda”) today announced a mutual agreement with IDT Biologika GmbH (“IDT”), a contract development and manufacturing organization, to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture the single-shot COVID-19 vaccine developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. At the end of a three-month period, the capacity will be returned to Takeda to resume critical manufacturing for the planned launch of its dengue vaccine, subject to regulatory approvals.
Takeda and IDT Support Manufacturing of Johnson & Johnson's COVID-19 Vaccine | Business cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.
5 Most Valuable Australian Companies
In this article, we are going to list the
5 Most Valuable Australian Companies. To read our detailed analysis of the Australian economy, please go to the
Market cap: $86.8 billion
Melbourne-based biotech giant CSL Limited ranks 5th on our list of the 15 most valuable Australian companies. The company develops plasma therapies through its CSL Behring segment and produces influenza vaccines through its CSL Seqirus segment. In February 2021, CSL announced its partnership with AstraZeneca (LON: AZN) to produce 30 million doses of the Oxford University vaccine. CSL has also joined the COVIg-19 Plasma Alliance, which develops anti-coronavirus hyperimmune intravenous immunoglobulin (H-Ig) medicine to treat hospitalized adults at risk of severe complications of COVID-19. Microsoft (NASDAQ: MSFT) provides technical support in the COVIg-19 Plasma Alliance website and Plasma Bot for donor recruitment.